Mengting Li
- Molecular Medicine top 10%
- Pharmaceutical Science top 5%
- Biomaterials top 10%
-
- Protease and Inhibitor Mechanisms 5
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics 7
-
- Peptidase Inhibition and Analysis 7
- Cutaneous Melanoma Detection and Management 5
- Cancer Immunotherapy and Biomarkers 5
-
- RNA modifications and cancer 6
-
- Advanced Fluorescence Microscopy Techniques 4
-
- Radiopharmaceutical Chemistry and Applications 4
- Journals
- Angewandte Chemie International Edition (1 paper)Nano Letters (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesIran
In The Last Decade
Mengting Li
57 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 127
- Molecular Medicine 70
- Pharmaceutical Science 68
- Biomaterials 140
- Cancer Research 143
- Biomedical Engineering 319
Countries citing papers authored by Mengting Li
This map shows the geographic impact of Mengting Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengting Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengting Li more than expected).
Fields of papers citing papers by Mengting Li
This network shows the impact of papers produced by Mengting Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengting Li. The network helps show where Mengting Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mengting Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 5 | |
| 7 | 2022 | 7 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 1 | |
| 10 | 2022 | 15 | |
| 11 | 2022 | 42 | |
| 12 | 2022 | 79 | |
| 13 | 2021 | 16 | |
| 14 | 2019 | 7 | |
| 15 | 2019 | 144 | |
| 16 | 2019 | 13 | |
| 17 | 2017 | 1 | |
| 18 | 2017 | 11 | |
| 19 | 2016 | 13 | |
| 20 | 2015 | 15 |
About Mengting Li
Mengting Li is a scholar working on Structural Biology, Biophysics and Cancer Research, having authored 62 papers that have together received 1.1k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (7 papers), Peptidase Inhibition and Analysis (7 papers), RNA modifications and cancer (6 papers), Protease and Inhibitor Mechanisms (5 papers), Cutaneous Melanoma Detection and Management (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Advanced Fluorescence Microscopy Techniques (4 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). The work is most often cited by research in Molecular Medicine (70 citations), Pharmaceutical Science (68 citations) and Biomaterials (140 citations). Mengting Li has collaborated with scholars based in China, United States and Iran. Frequent co-authors include Xiaoli Lan, Weibo Cai, Ross Crawford, Fei Wei, Yinghong Zhou, Yin Xiao, Yongxue Zhang, Yongkang Gai, Hongyu Ji and Nannan Zheng. Their work appears in journals such as Angewandte Chemie International Edition, Nano Letters and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.